ChromaDex Obtains Additional Working Capital
ChromaDex Corp. (Irvine, CA) raised $4.2 million through a private placement stock offering that began in March, the company said on August 8. New Castle Financial Services (New York City) acted as the private placement agent for the transaction, which yielded gross proceeds of $4.67 million.
ChromaDex Corp. (Irvine, CA) raised $4.2 million through a private placement stock offering that began in March, the company said on August 8.
New Castle Financial Services (New York City) acted as the private placement agent for the transaction, which yielded gross proceeds of $4.67 million.
“Subsequent to our recent emergence as a publicly traded company through completion of a reverse merger, today we are pleased to announce the closing of this private placement to provide ChromaDex with additional working capital to support our business expansion plans,” said ChromaDex cofounder and CEO Frank Jaksch. “We are pleased with the amount raised and confident this financing will help position ChromaDex to support the next phase of our growth in our quest to become the premier provider of phytochemical and botanical reference standards to the functional food, cosmetic, dietary supplement, pharmaceutical, life sciences, and other industries.”
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
